Article PDF
Avoid common mistakes on your manuscript.
References
Haria M, Bryson HM. Amorolfine. A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections. Drugs 1995; 49: 103–20
del Palacio A, Gip L, Bergstraesser M, et al. Dose-finding study of amorolfine cream (0.125%, 0.25% and 0.5%) in the treatment of dermatomycoses. Clin Exp Dermatol 1992; 17 Suppl. 1: 50–5
Nolting S, Semig G, Friedrich HK, et al. Double-blind comparison of amorolfine and bifonazole in the treatment of dermatomycoses. Clin Exp Dermatol 1992; 17 Suppl. 1: 56–60
Nolting S, Reinel D, Semig G, et al. Amorolfine spray in the treatment of foot mycoses (a dose-finding study). Br J Dermatol 1993; 129: 170–4
Hay RJ. Onychomycoses. Agents of choice. Dermatol Clin 1993; 11: 161–9
Roberts TD. Prevalence of dermatophyte onychomycosis in the United Kingdom: results of an omnibus survey. Br J Dermatol 1992; 126 Suppl. 39: 23–7
Roberts DT. Oral therapeutic agents in fungal nail disease. J Am Acad Dermatol 1994; 31 (3 Pt 2): 78–81
Lauharanta J. Comparative efficacy and safety of amorolfine nail lacquer 2% versus 5% once weekly. Clin Exp Dermatol 1992; 17 Suppl. 1: 41–3
Reinel D, Clarke C. Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis, once-weekly versus twice-weekly. Clin Exp Dermatol 1992; 17 Suppl. 1: 44–9
Lauharanta J, Zaug M, Polak A, et al. Combination of amorolfine with griseofulvin: in vitro activity and clinical results in onychomycosis. JAMA South East Asia 1993; 9 Suppl. 4: 23–7
Hay RJ, Clayton YM, Moore MK, et al. An evaluation of itraconazole in the management of onychomycosis. Br J Dermatol 1988; 119: 359–66
Hay RJ, Roberts DT, Doherty VR, et al. The topical treatment of onychomycosis using a new combined urea/imidazole preparation. Clin Exp Dermatol 1988; 13: 164–7
British National Formulary No. 28. London: The Pharmaceutical Press, 1994; 449–51
Hay RJ, Mackie RM, Clayton YM. Tioconazole nail solution — an open study of its efficacy in onychomycosis. Clin Exp Dermatol 1985; 10: 111–5
Rights and permissions
About this article
Cite this article
Amorolfine: topical therapy for mild onychomycosis. Drugs Ther. Perspect 5, 4–7 (1995). https://doi.org/10.2165/00042310-199505050-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199505050-00002